CCL17 (TARC) levels in 53 cHL patients at DIA and 5 HDs were measured, and a significant increase in CCL17 (TARC) (p-value: ≤0.0001) was found (Figure 5A). The gene discussed is CCL17; the disease is classic Hodgkin lymphoma.